Company Filing History:
Years Active: 2014-2022
Title: Innovations and Contributions of Inventor Tai-Lung Cha
Introduction
Tai-Lung Cha is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of four patents to his name, his work has garnered attention for its innovative approaches to combating cancer.
Latest Patents
One of Tai-Lung Cha's latest patents is focused on ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one and their uses. This patent discloses a compound that serves as an ammonium salt of GW5074, which can be utilized in a pharmaceutical kit for cancer treatment. The kit includes a formulation comprising a c-Raf inhibitor and a second formulation with the compound of formula (I). The method of treating cancer involves detecting phosphorylation on serine 308 of death-associated protein kinase (DAPK) and administering effective amounts of the c-Raf inhibitor and the compound based on the detection results. Another patent highlights a pharmaceutical composition that combines sorafenib and GW5074, which inhibits cancer cell growth through the c-Raf-PP2A-DAPK signaling pathway.
Career Highlights
Tai-Lung Cha has worked with notable organizations such as the National Defense Medical Center and Metagone Biotech Inc. His experience in these institutions has contributed to his expertise in pharmaceutical innovations and cancer research.
Collaborations
Some of his coworkers include Yi-Ta Tsai and Sun-Yran Chang, who have collaborated with him on various projects related to his patents and research.
Conclusion
Tai-Lung Cha's innovative work in the field of pharmaceuticals, particularly in cancer treatment, showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective therapies that can significantly impact patient care.